Health Boards
›
Psoriasis In The News
Vitae announce RORyt Inhibitor VTP-43742 phase 1 results
|
Vitae announce RORyt Inhibitor VTP-43742 phase 1 results
|
Sat-12-09-2015, 19:13 PM
(Sat-12-09-2015, 16:58 PM)AmandaL Wrote: Don't know if I trust them. It's inflammatory bowel disease not irritable Good observation Amanda, I can see your point. Tut Tut Vitae Pharmaceuticals, you should spend a little time checking what you say.  *That'll make the Brandwatch Bot get a little excited. 
|
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
Vitae announce RORyt Inhibitor VTP-43742 phase 1 results - by Fred - Tue-08-09-2015, 21:57 PM
RE: Vitae announce RORyt Inhibitor VTP-43742 phase 1 results - by AmandaL - Sat-12-09-2015, 16:58 PM
RE: Vitae announce RORyt Inhibitor VTP-43742 phase 1 results - by Fred - Sat-12-09-2015, 19:13 PM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
CAL101 phase 1 on patients with psoriasis | Fred | 6 | 842 |
Fri-25-10-2024, 15:51 PM Last Post: Fred |
|
|
Piclidenoson for psoriasis phase 3 results | Fred | 1 | 3,235 |
Fri-02-02-2024, 20:04 PM Last Post: Caroline |
|
|
Skyrizi long term results for psoriasis | Fred | 16 | 5,755 |
Wed-10-01-2024, 21:16 PM Last Post: Caroline |
|
|
JNJ-2113 for psoriasis Phase 2b results | Fred | 4 | 3,486 |
Wed-12-07-2023, 11:52 AM Last Post: Turnedlight |
|
|
Tremfya for psoriatic arthritis phase 3b data | Fred | 0 | 1,486 |
Wed-31-05-2023, 16:26 PM Last Post: Fred |
